About Drugs Made In America Acquisition Corp - Units (1 Ord Shs & 1 Rts)
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida.
Full DMAAU analysis →
Competitive advantage assessment
The dashed ring is the peer median. Defense scores are percentile ranks
against peers, so 50 is roughly the typical company in this group.
Upgrade to unlock the signals and evidence behind each defense.
Premium access
Unlock full defense analysis
Get key signals, strengths, and risks for every moat dimension.
Drugs Made In America Acquisition Corp - Units (1 Ord Shs & 1 Rts) ranks #201 of 316
scored companies in Shell Companies by moat score — the top 64%.
The widest moat in the group is AI TRANSPORTATION ACQUISITION C (AITR)
at 97/100.
Moat scores for companies ranked near DMAAU in Shell Companies
How DMAAU scores on the Corporate Default defenses
Pricing Power
Not measurable
· 20% of the moat score
Pricing power is the ability to raise prices without losing volume.
Cost Advantage
Not measurable
· 15% of the moat score
A cost advantage means delivering the same product for structurally less — better purchasing, denser distribution, a more automated process.
Customer Stickiness
Not measurable
· 15% of the moat score
Stickiness is what makes revenue repeat without being re-won every year.
Capital Efficiency
Score 24
· 18% of the moat score
Capital efficiency asks what the company earns on the money tied up in the business.
Resilience
Score 31
· 17% of the moat score
Resilience is the capacity to get through a bad year on its own terms — enough liquidity, enough interest cover, and enough cash generation to avoid a rescue financing or a forced sale.
Scale & Market Position
Not measurable
· 15% of the moat score
Scale matters only when it converts into economics.
What is Drugs Made In America Acquisition Corp - Units (1 Ord Shs & 1 Rts)'s moat score?
Drugs Made In America Acquisition Corp - Units (1 Ord Shs & 1 Rts) (DMAAU) scores 27 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as developing. It ranks #201 of 316 scored companies in Shell Companies, the top 64%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 315 companies in Shell Companies. Its strongest defense is Resilience (31/100) and its weakest is Capital Efficiency (24/100).
How does Drugs Made In America Acquisition Corp - Units (1 Ord Shs & 1 Rts) compare with other Shell Companies companies?
Drugs Made In America Acquisition Corp - Units (1 Ord Shs & 1 Rts) ranks #201 of 316 scored companies in Shell Companies by moat score. The widest moat in Shell Companies is AI TRANSPORTATION ACQUISITION C (AITR) at 97/100. The companies ranked closest are Cantor Equity Partners I, Inc. (CEPO) at 27 just above it and Newbury Street Acquisition Corp (NBSTU) at 27 just below it.
How is the moat score calculated?
Each company is scored with an industry-specific template — Corporate Default in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 315 companies in Shell Companies. The defenses are then weighted to produce the overall score out of 100.
Why is Drugs Made In America Acquisition Corp - Units (1 Ord Shs & 1 Rts) scored with the Corporate Default template?
Most public companies sell a product or a service at a margin, so the moat question is whether that margin survives contact with competitors. The Corporate template scores the six defenses that show up in a general operating company's financial signature: whether it can hold price, produce more cheaply than rivals, keep its customers, earn a return above its cost of capital, withstand a downturn, and turn size into economics.
Which competitive defenses are measured for Drugs Made In America Acquisition Corp - Units (1 Ord Shs & 1 Rts)?
The Corporate Default template measures 6 defenses, and DMAAU scores: Pricing Power (not measurable), Cost Advantage (not measurable), Customer Stickiness (not measurable), Capital Efficiency (24), Resilience (31), Scale & Market Position (not measurable). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.
We value your privacy
We use cookies to enhance your browsing experience, analyze site traffic, and personalize content. By clicking 'Accept All', you consent to our use of cookies.
Read our cookie policy
Cookie Preferences
Manage your cookie preferences. Essential cookies are always enabled.